Cell-to-cell communication is essential for the immune system to generate protective responses. Contact-independent communication entails the transmission of information through the diffusion of soluble factors, whereas contact-dependent communication involves physical connections through specialized areas of contact. Short-range connections are composed of gap junctions and synapses, whereas long-range connections encompass nanotubules and filopodial bridges 1 . Similar to cytonemes originating from the drosophila imaginal disc, long-distance intercellular conduits allow complex messages to travel between distant cells without crossing the plasma membrane and without decreasing in strength relative to the distance traveled 2 . Although nanotubules can move both surface and cytoplasmic proteins, filopodial bridges transfer surface proteins only 3 . By establishing intercellular connectivity networks, these cell protrusions may enable immune cells to amplify protective responses without relying on the slower process of diffusion 4 .
A downside of contact-dependent communication systems is that pathogens may 'hijack' them to undergo cell-to-cell spreading. This process is exemplified by human immunodeficiency virus type 1 (HIV-1), the etiological agent of AIDS. HIV-1 uses a specialized area of immune contact known as the 'virological synapse' to spread from dendritic cells or macrophages to CD4 + T cells 5 . In addition, HIV-1 uses intercellular conduits for efficient cell-to-cell transmission, as other retroviruses do 6, 7 . These conduits might also spread viral subunits with immunosuppressive function, which could allow HIV-1 to cause extensive damage to immune cells without infecting them 8, 9 . One viral immunosuppressive protein possibly linked to intercellular transportation is negative factor (Nef), a membrane-targeting accessory protein involved in AIDS development and immune dysfunction 10, 11 .
Nef targets cell membranes and elicits cytoskeletal rearrangement, organelle formation and synapse destabilization [12] [13] [14] [15] , all events involved in protein trafficking through intercellular conduits 3 . In addition, Nef accumulates in macrophages, a conduit-forming cell type often proximal to Nef-containing B cells in infected follicles 8 . As B cells are generally not infected by HIV-1, they might acquire Nef from neighboring infected macrophages through nanotubules or filopodial bridges. This transfer could attenuate the production of immunoglobulin G (IgG) and IgA 8 , two antibody isotypes with antiviral activity 16 .
HIV-1 causes many B cell abnormalities, including hyperproduction of nonspecific IgG and IgA antibodies 17, 18 . In addition, HIV-1 elicits robust virus-specific IgG responses. Although IgG antibody to viral envelope (Env) glycoproteins remains sustained throughout the disease, IgG antibody to group antigen (Gag) and other viral proteins progressively decreases 19, 20 . This decrease more conspicuously involves the IgG2 subclass, which is involved in recognition of microbial carbohydrates, possibly including viral glycoproteins, whereas IgG1 and IgG3 subclasses are less affected 21 . Additional B cell abnormalities include poor intestinal IgA responses to Env glycoproteins, defective IgG and IgA responses to opportunistic pathogens and vaccines, and loss of memory B cells, a subset of class-switched and high-affinity B cells that originate from the germinal center (GC) of secondary lymphoid follicles [22] [23] [24] .
In general, HIV-1-induced humoral defects are thought to originate from activation-induced B cell exhaustion and progressive loss of CD4 + T cells, a subset of T cells that provides help to follicular B cells through interactions between the costimulatory molecule CD40 and its ligand (CD40L) [25] [26] [27] [28] . Yet normalization of CD4 + T cells by antiretroviral therapy does not fully restore antigen-specific IgG and IgA responses and memory B cells 29, 30 , which suggests the additional involvement of B cell-intrinsic defects. Consistent with that possibility, B cells from infected patients show less responsiveness to CD4 + T cell help through CD40L 31 .
Here we show that HIV-1-infected macrophages formed long-range B cell-targeting conduits in response to Nef. These conduits inhibited systemic and intestinal IgG2 and IgA class switching by translocating membrane-bound Nef as well as Nef-containing endosomes from macrophages to follicular B cells through a mechanism propelled by actin (A000191), mediated by Vav (A002361) and dependent on GTPase that involved the myristoylated anchor, central core and flexible loop domains of Nef. Those findings together with additional in vivo data obtained from patients infected by Nef-sufficient or Nef-deficient virions suggest that HIV-1 uses long-distance intercellular 'highways' as a 'Trojan horse' to deliver Nef to B cells and evade protective virus-specific IgG2 and IgA responses systemically and at mucosal sites of entry.
RESULTS

HIV-1-infected macrophages transfer Nef to B cells
Nef enhances HIV-1-induced antibody abnormalities by attenuating CD40L expression on CD4 + T cells, hindering CD4 + T cell interactions with antigen-presenting cells and augmenting nonspecific B cell activation through macrophages 15, 27, 32 . These effects promote nonspecific hypergammaglobulinemia while hampering specific T celldependent IgG and IgA responses. Nef also invades follicular B cells, thereby interfering with the initiation of class switch-inducing signals from CD40L 8 . As macrophages are critical in the translocation of viral antigens to follicular B cells 33 , we hypothesized that B cells acquire Nef through a contact-dependent mechanism involving macrophages.
Immunohistochemistry showed abundant CD68 + macrophages containing p24 and Nef in follicular and extrafollicular areas of infected lymphoid tissues (Fig. 1a) . Together with HIV-1-trapping follicular dendritic cells, these infected macrophages correlated with less abundant IgG2 and IgA in systemic and intestinal GCs (Fig. 1b and Supplementary Fig. 1 ). Of note, infected macrophages were often proximal to preswitched IgD + B cells that contained Nef but lacked p24 (Fig. 1c) . Flow cytometry confirmed the presence of Nef but not p24 in purified B cells from infected lymphoid follicles (Fig. 1d) .
Flow cytometry and immunofluorescence analysis demonstrated that IgD + B cells acquired Nef but not p24 after 24 h of exposure to macrophages containing either ADA, an R5 strain of HIV-1 that uses the chemokine receptor CCR5 to enter macrophages and CD4 + T cells, or LAI, an X4 strain of HIV-1 that uses CXCR4 to infect CD4 + T cells as well as macrophages ( Fig. 1e and Supplementary Fig. 2 ). We obtained similar results by culturing U1 macrophage-like cells containing a tumor necrosis factor (TNF)-inducible virus together with IgD + B cells prelabeled with CellTracker reagent (Supplementary Fig. 3 ). This compound passes freely through cell membranes but after internalization is transformed into a cell-impermeant adduct that remains inside live cells for several generations. This strategy allowed us to monitor and quantify by confocal microscopy the transfer of Nef and p24 to B cells. Unlike unstimulated HIV-1 À U1 cells or the parental HIV-1 À U937 cells (data not shown), TNF-stimulated HIV-1 + U1 cells contained Nef and p24, released p24, and transferred Nef but not p24 to B cells in a time-dependent way. Together these data indicate that B cells acquire Nef from infected macrophages.
HIV-1-infected macrophages inhibit class switching
Because the accumulation of Nef-containing macrophages correlates with attenuated production of IgG2 and IgA in HIV-1-containing GCs, we sought to verify whether infected macrophages inhibit class switching through Nef. We first cultured IgD + B cells for 24 h together with uninfected or HIV-1-infected macrophages and then sorted the cells and exposed them to T cell-dependent signals such as CD40L and interleukin 10 (IL-10). We evaluated class switching by enzyme-linked immunosorbent assay (ELISA) and quantitative RT-PCR. Compared with B cells exposed to uninfected macrophages (Fig. 1f) , B cells exposed to infected macrophages secreted less IgG and IgA in response to CD40L and IL-10 and expressed fewer AICDA transcripts (encoding activation-induced cytidine deaminase (AID)), a hallmark of ongoing class-switch recombination (CSR) of DNA 34 .
The inhibitory effects described above were reversed when we incubated the B cells with macrophages containing Nef-deficient (DNef) HIV-1. Restoration of class switching was not due to differences in viral replication, because macrophages infected with Nef-sufficient and DNef virions released similar amounts of p24. We obtained similar results by incubating B cells with TNF-stimulated HIV-1 + U1 macrophage-like cells or with 293 epithelial cells expressing wild-type or DNef HIV-1 plasmids ( Supplementary Fig. 3 ). Supernatants from HIV-1 + U1 cells or primary macrophages (data not shown) did not affect class switching, which indicated that infected macrophages rendered B cells less sensitive to T cell-dependent class switch-inducing signals through a contact-dependent mechanism involving Nef.
Macrophages inhibit class switching via Nef
To determine whether Nef is sufficient for macrophages to acquire class switch-inhibiting functions, we incubated human macrophage-like 
Nef accumulation correlates with GC alterations
Given the lower expression of IgG2 and IgA in infected GCs and the AICDA-inhibiting activity of infected macrophages, we verified the expression of AID in vivo by immunohistology. In contrast to HIV-1 À GCs, HIV-1 + GCs accumulated Nef, and HIV-1 + GCs contained less AID than did HIV-1 À GCs (Fig. 2h,i and Supplementary Fig. 4 and Table 1 ). The attenuation of AID expression correlated with lower expression of Bcl-6 and IRF4, two factors required for GC B cell differentiation and class switching 35 , and with higher expression of Blimp-1 and CD138 (Supplementary Figs. 5 and 6), a Bcl-6-suppressing plasma cell-inducing protein and a plasma cell hallmark, respectively 36 . Consistent with published data indicating that Nef inhibits AID expression and class switching by attenuating activation of the transcription factor NF-kB mediated by CD40L and dependent on the IkB kinase IKK, as well as activation of the transcription factor STAT6 mediated by IL-4 and dependent on the kinase Jak3 (ref. 8) , HIV-1 + AID lo GCs also showed less phosphorylation of IKK, Jak3 and STAT6 and higher expression of IkB and SOCS protein, which are Nef-inducible inhibitors of NF-kB and STAT6, respectively 8 . These alterations were not associated with loss of GC B cells, as HIV-1 + GCs had normal expression of Ki67 and the nuclear factor Pax5, two hallmarks of GC B cells 36 . Finally, HIV-1 + AID lo GCs had conserved or more CD21 + CD35 + follicular dendritic cells, CD4 + T cells and CD40L expression, at least in systemic lymph nodes. Thus, Nef may inhibit AID expression and class switching in the context of an overall perturbation of the GC reaction.
Nef induces B cell-targeting conduits through multiple motifs
Nef 'reprograms' endocytosis, cytoskeleton rearrangement, organelle trafficking and cell signaling to downregulate CD4 and human leukocyte antigen I (HLA-I) on infected cells and induce immune suppression 11 . All these events are also involved in intercellular trafficking 1, 3 . To elucidate the molecular requirements underlying the induction of B cell-targeting conduits in macrophages, we generated THP-1 cells expressing wild-type Nef or Nef mutants with inactive 1MGxxxS6, 72PxxPxR77, 156ExxxLL161 or 62EEEE65 motifs, respectively (where 'x' is any amino acid and numbers indicate positions of initial and final amino acids in the sequence).
The sequence 1MGxxxS6 is a myristoylated motif from the aminoterminal anchor of Nef that binds Nef to the plasma membrane, an event essential for most Nef functions 13 . The sequence 72PxxPxR77 is a proline-rich motif from the central core of Nef that induces actin cytoskeleton remodeling, endosome formation and signaling by interacting with many kinases, including Vav 12, 37 . The sequence 62EEEE65 is an acidic cluster from the central core of Nef that promotes the recruitment of Nef-containing endosomes to the trans-Golgi network (TGN) by interacting with PACS-1, a component of the clathrinindependent endocytic pathway 14 . Finally, 156ExxxLL161 is a di-leucine motif from the carboxy-terminal flexible loop of Nef that elicits the formation of Nef-and CD4-containing endosomes by interacting with the adaptor protein AP-2, a key component of the clathrin-dependent endocytic pathway [38] [39] [40] . Confocal microscopy showed that unlike control eGFP, Nef-eGFP targeted the plasma membrane and a perinuclear compartment of THP-1 cells and induced thin protrusions bridging THP-1 cells with each other and with B cells (Fig. 3a-c and Supplementary Movies 1 and 2). Inactivation of 1MGxxxS6 altered the subcellular distribution of Nef, abrogated cell protrusions, and impaired the transfer of Nef to B cells. Inactivation of 72PxxPxR77 or 156ExxxLL161 did not disrupt the subcellular localization of Nef but did attenuate cell protrusions and the transfer of Nef to B cells. Inactivation of 62EEEE65 neither altered Nef localization nor affected cell protrusions but did attenuate the transfer of Nef to B cells. Thus, anchoring of Nef to the plasma membrane is essential for Nef to stimulate conduit formation in macrophages and invade B cells. These effects may also require 'reprogramming' of macrophage signaling and endocytosis.
Nef traffics to B cells through long-range intercellular conduits
We next sought to determine whether Nef-induced macrophage protrusions develop into long-range conduits. Confocal microscopy showed that Nef-containing THP-1 macrophage-like cells formed an intricate network of conduits targeting distant THP-1 cells or CellTracker-loaded IgD + B cells ( Fig. 3d and Supplementary Figs. 7 and 8) . Some conduits contained Nef along their entire length, whereas others encompassed organellelike bulges loaded with Nef. Time-lapse confocal microscopy of cocultures consisting of THP-1 cells activated with lipopolysaccharide, a conduit-inducing bacterial product 4 , and preloaded with LysoTracker, a probe that marks late endosomes and lysosomes, confirmed that B cell-targeting conduits trafficked organelles in addition to Nef through both short-range and long-range mechanisms ( Fig. 3e and Supplementary Movie 3). After establishing an initial contact, some conduits remained anchored to B cells for a few seconds to a few minutes ( Supplementary Fig. 9 ). During this time, B cells accumulated Nef in membrane and submembrane regions proximal to the conduit. Further experiments showed directional movement of Nef-eGFP from THP-1 cells to B cells along conduits ( Supplementary Fig. 10 ).
To rule out the possibility that intercellular conduits resulted from the artificial activation of THP-1 cells by overexpressed Nef-eGFP, we studied the formation of these conduits in primary macrophages infected by HIV-1. Staining with the membrane-targeting lectin wheat germ agglutinin (WGA) showed that macrophages formed more long-range conduits after infection with ADA HIV-1 ( Fig. 4a and Supplementary Movie 4) . This enhancement was less pronounced in macrophages infected with DNef ADA. Of note, long-range conduits generated by ADA-infected macrophages contained both Nef and p24 (Fig. 4b,c) . Together with shortrange conduits, these long-range conduits trafficked Nef (Fig. 4d) but not p24 (data not shown) to Pax5 + B cells. Thus, infected macrophages translocate both membrane-bound and organelle-associated Nef proteins to B cells through long-range intercellular 'highways' .
Nef invades B cells via macrophage actin remodeling
Given that cells require ATP-dependent remodeling of their actin cytoskeleton to form conduits 1, 3 , we wondered about the function (Fig. 4e) . As Nef uses phosphoinositol-3-OH kinase and ADP-ribosylation factor 6 (ARF6) to promote clathrin-independent recruitment of HLA-Icontaining Nef -endosomes to the TGN 14 , we also explored the function of phosphoinositol-3-OH kinase in this. We found that conduit formation and Nef transfer were not affected by the phosphoinositol-3-OH kinase inhibitor wortmannin. As CCR5 and CXCR4 mediate intercellular communication and HIV-1 transmission 5 , we determined the function of these chemokine receptors as well. Consistent with the expression of CXCR4 but not CCR5 by B cells 26 , a CXCR4 inhibitor attenuated the transfer of Nef to B cells, whereas a CCR5 inhibitor did not. Neither inhibitor affected conduit formation. Knowing that Nef induces actin rearrangement by interacting with the guanine nucleotide-exchange factor Vav through 72PxxPxR77 (ref. 12), we also addressed the function of Vav and 'downstream' small GTPases in Nef-induced conduit formation and B cell invasion.
We found that dominant negative constructs of Vav or Cdc42, Rac-1 and Rho small GTPases inhibited conduit formation by THP-1 cells as well as the transfer of Nef-eGFP from THP-1 cells to B cells (Fig. 4f) . Thus, macrophages translocate Nef to B cells by a Vav-mediated, small GTPase-dependent mechanism that involves actin-propelled intercellular conduits. Some of these conduits may navigate toward and interact with B cells by a CXCR4-dependent mechanism.
Nef invades B cells via membrane and vesicular routes
Given that Nef uses endosome-regulating 156ExxxLL161 and 62EEEE65 motifs to invade B cells and knowing that organelles can navigate along conduits 1-3 , we sought to determine whether Nef translocates from macrophages to B cells in vesicular cargo. Dominant negative constructs of b-arrestin-2 (A000027) and dynamin Ia (A000794), which regulate clathrin-dependent formation of endosomes containing CD4 and Nef 14, 39, 41 , attenuated the transfer of Nef-eGFP from THP-1 cells to B cells, whereas a dominant negative construct of ARF6, which regulates the clathrin-independent formation of Nef -endosomes containing HLA-I (ref. 14) , did not.
Confocal imaging documented Nef-containing organelle-like bulges positive for a membrane-specific dye along long-range conduits that (Fig. 5a) . Some of these bulges stained positively for b-adaptin or TGN46 (Fig. 5b,c) , which suggested their origin in clathrin-dependent or clathrin-independent (TGN-derived) pathways 14, 39 , respectively. Electron microscopy confirmed that the conduits consisted of Nef-containing vesicular and tubular structures in addition to membrane-bound Nef and additionally showed Nef + structures budding from the surface of THP-1 cells, navigating in the extracellular space between macrophage-like cells and B cells, and docking on the surface of B cells adjacent to macrophage-like cells (Fig. 5d) . Confocal microscopy showed that some of these extracellular structures involved clathrin, as they were positive for b-adaptin (Fig. 5e) .
We next sought to determine whether trafficking of Nef through intercellular conduits affected class switching. We found that NefeGFP-THP-1 cells reversed their ability to inhibit IgA and IgG2 class switching in CD40-activated IgD + B cells in the presence of mutations inactivating Nef membrane-anchoring motifs (1MGxxxS6), cytoskeleton-remodeling motifs (72PxxPxR77) and 'endosomereprogramming' motifs (156ExxxLL161 and 62EEEE65) or in the presence of dominant negative constructs of Vav, b-arrestin-2, dynamin Ia, Cdc42, Rac-1 or Rho but not ARF6 (Fig. 5f,g and Supplementary Fig. 11) . Thus, inhibition of class switching by infected macrophages probably involves the transfer of Nef to B cells through the plasma membrane and both clathrin-dependent and clathrinindependent (but ARF6-negative) vesicular structures.
Nef inhibits virus-specific IgG2 and IgA responses in vivo
Having shown less IgG2 and IgA class switching in Nef-containing follicles, we sought to determine whether these lymphoid structures included Nef-trafficking B cell-targeting conduits. Systemic and intestinal follicles from HIV-1 À and HIV-1 + subjects consisted of B cells connected with each other or macrophages through long-range conduits bearing membrane-bound CD19 (Fig. 6a,b and Supplementary Fig. 12 ). In HIV-1 + subjects, some conduits contained Nef and targeted Nef-containing B cells. Unlike HIV-1 + follicular areas, HIV-1 + extrafollicular areas contained little or no Nef and showed florid class switching, including expression of AID, IgA (Fig. 6c) and IgG (data not shown). Extrafollicular class switching correlated with CD68 + macrophages expressing ferritin and BAFF (Fig. 6d,e) , two HIV-1-inducible molecules with innate B cell-activating function 26, 27, 34, [42] [43] [44] . Despite inducing more ferritin than uninfected macrophages did (Fig. 6f) , infected macrophages did not use ferritin to inhibit T cell-dependent class switching. Instead, ferritin acted together with BAFF to increase T cell-dependent production of IgG and IgA but not IgM (Fig. 6g) .
Long-term nonprogressors (LTNPs; patients infected with HIV whose infection does not progress to AIDS) infected with DNef HIV-1 had more circulating ferritin than did LTNPs infected with wild-type HIV-1 ( Supplementary Fig. 13 ), which further discounted the possibility of the involvement of ferritin in the inhibition of class switching by Nef. Despite having similar viral and immunological parameters 45 , including low viral load, normal CD4 + T cell counts and normal total serum IgM, IgG and IgA antibodies ( Supplementary Fig. 13 and Table 2 ), DNef-HIV-1 + LTNPs had more IgG2, IgA1 and IgA2 antibodies to viral p24, Tat (transactivator of transcription) and Env gp120 than wild-type HIV-1 + LTNPs did (Fig. 7a) . When monitored over time, these HIV-1-specific antibodies, as well as ferritin, showed no positive correlation with the viral load ( Fig. 7b and Supplementary Fig. 14) , which confirmed that DNef HIV-1 enhances antiviral immunity independently of viral replication. Thus, we propose that HIV-1 attenuates virus-specific CD40-dependent IgG2 and IgA responses in Nef-rich GC areas by trafficking Nef from infected macrophages to follicular B cells through long-range conduits. Furthermore, we argue that HIV-1 boosts nonspecific CD40-independent IgG and IgA responses by upregulating the production of polyclonal B cellactivating molecules such as ferritin and BAFF in macrophages from Nef-poor extra-GC areas (Supplementary Fig. 15) . HIV-1 has evolved many strategies to evade antibody recognition, including poor antigenicity, limited immunogenicity, great variability and conformational camouflage of Env glycoproteins, which are essential for viral entry 46 . Additional strategies impair antibody production by inducing CD4 + T cell depletion, activation-induced B cell anergy, polyclonal B cell population expansion and loss of memory B cells 18, 24, 25, 27, 28 . Although they are more prominent with active viral replication, these humoral defects persist in aviremic patients who are receiving antiretroviral therapy 24, 29, 30 , which suggests the existence of replication-independent mechanisms for antibody evasion. One of these mechanisms involves the targeting of systemic and intestinal B cells by Nef-trafficking conduits emerging from infected macrophages.
IgG and IgA are important in the control of HIV-1 infection both systemically and at mucosal sites of entry 46 . By showing that LTNPs positive for DNef HIV-1 had more virus-reactive IgG2 and IgA than did LTNPs positive for wild-type HIV-1, our studies have provided in vivo evidence that HIV-1 perturbs the antiviral response of systemic and mucosal B cells by a mechanism involving Nef. This mechanism is replication independent, because both groups of LTNPs had similar viral loads and CD4 + T cell counts and showed neither B cell hyperactivation nor hypergammaglobulinemia. Furthermore, when examined over time, virus-specific antibodies did not correlate with the viral load in LTNPs positive for DNef HIV-1. Like patients exposed to antiretroviral therapy 47 As suggested by published studies 9, 48 , HIV-1 probably promotes the intercellular trafficking of multiple viral subunits to hamper the function of both cells of the immune system and cells not of the immune system. In addition to expressing Nef, HIV-1 expresses Vif (virus infectivity factor) and Vpr (viral protein R). These accessory proteins accumulate in infected GCs (P.A.S. and A.C., unpublished data) and inhibit the function of AID and UNG (uracil DNA glycosylase), respectively, two enzymes essential for class switching and somatic hypermutation [49] [50] [51] . Should Vif and Vpr traffic to B cells as Nef does, HIV-1 would have a powerful arsenal for inhibiting both affinity maturation and class switching in GCs. This inhibition may contribute not only to the loss of class-switched memory B cells in both viremic and aviremic patients 24, 29 but also to the paucity of rapid and sustained neutralizing IgG and IgA responses to invading virions 46 .
When exposed to Nef-containing macrophages, B cells acquired Nef and became less responsive to T cell-dependent class switch-inducing signals, in that they expressed less AID and underwent less IgG2 and IgA CSR and production in response to CD40L. Those in vitro data were supported by in vivo observations showing massive Nef accumulation as well as attenuated AID expression and less production of IgG2 and IgA in infected GCs. Of note, the inhibition of AID expression was somewhat more evident in infected lymphoid tissues than in cocultures of B cells and infected macrophages, possibly reflecting the fact that the class switch-inhibiting mechanisms acting in vivo are more complex than those present in vitro. In this context, Nef accumulation in GCs was associated with lower expression of the GC-inducing factor Bcl-6 and with higher expression of the GCinhibiting factor Blimp-1 (ref. 36) . The latter may impair class switching by silencing AID expression and triggering premature plasma cell differentiation 36 . Tissue data also provided in vivo correlates to published in vitro findings showing that Nef impairs T celldependent class switching by impeding CD40 and cytokine receptor signaling through NF-kB and STAT by a mechanism involving upregulation of negative-feedback proteins such as IkBa and SOCS 8 .
GC abnormalities were dissociated from an obvious loss of follicular dendritic cells, CD4 + T cells and CD40L, which further suggested the involvement of B cell-intrinsic defects such as those brought about by Nef. This viral protein had a direct negative effect on B cells, as supernatants from HIV-1-infected macrophages did not show any inhibitory effect on class switching. In agreement with that observation, B cells capturing exogenous soluble Nef or expressing transfected endogenous Nef become less responsive to class switchinducing signals 8 .
Unlike GCs, extra-GC areas showed florid IgG and IgA class switching, which correlated with macrophage accumulation of HIV-1-inducible B cell-activating factors with innate class switch-inducing activity, such as ferritin and BAFF 26,27,34,42-44 . Our data suggest that Figure 7 The DNef HIV-1 elicits more virus-specific IgG2, IgA1 ferritin and BAFF act together to induce CD40-independent polyclonal activation of extrafollicular B cells, thereby contributing to the emergence of nonspecific hypergammaglobulinemia. The latter is an important cofactor in the pathogenesis of HIV-1-induced humoral deficiency 17, 26 and, together with nonprotective IgG1 responses to Env antigens, persists in AIDS patients with very few CD4 + T cells, which further suggests its origin in a CD40-independent pathway 17, 19 . Such a pathway may be insensitive to Nef, because this protein 'preferentially' targets CD40L, accumulates mainly in GCs and overrides its intrinsic B cell-inhibitory activity in extrafollicular areas by triggering ferritin production. Nonspecific CD40-independent responses may also involve Env, because Env augments BAFF production by engaging the canonical CD4, CCR5 and CXCR4 HIV-1 receptors on macrophages 26 . Env further activates extrafollicular B cells by engaging BAFF-inducible mannose C-type lectin receptors with class switchinducing activity 26 . These alternative HIV-1 receptors were not expressed by the resting B cells used in our studies here, which suggested that Env served a marginal function in the class switching events triggered by wild-type or DNef virions. Infected GCs were also characterized by the presence of long-range intercellular conduits that seemed to shuttle Nef from HIV-1-containing macrophages to uninfected B cells. Consistent with published studies showing that bacterial stimuli such as lipopolysaccharide stimulate intercellular conduit formation in uninfected macrophages 1 , we also found intercellular conduits in reactive HIV-1 À follicles, which suggested that HIV-1 'hijacks' a physiological intercellular communication network to disseminate viral immunosuppressive proteins to uninfected B cells. Infected macrophages enhanced the generation of long-range conduits through Nef. This accessory protein used its membrane-anchoring 1MGxxxS6 motif to progress along conduits, invade B cells and inhibit class switching. In addition to containing Nef, conduits emerging from infected macrophages contained p24. In agreement with published studies 7 , p24 was possibly associated with 'surfing' viral particles but, unlike Nef, was not transferred to B cells. That observation can be explained by the fact that conduit-associated p24-containing virions may invade only B cells expressing Envbinding mannose C-type lectin receptors 26 , which were rare in our cultures. It must be also considered that infected macrophages contained less p24 than Nef. Finally, p24 lacks membrane-targeting molecular moieties such as 1MGxxxS6, which was essential for the intercellular navigation of Nef.
The invasion of B cells by Nef would be favored by the presence of membrane continuity or receptor-dependent synaptic contact between conduits and targeted B cells 3 . Synaptic contact could indicate involvement of CXCR4, because an inhibitor of this chemokine receptor attenuated the trafficking of Nef from macrophages to B cells. Nef also required Vav-mediated, small GTPase-dependent cytoskeleton remodeling via 72PxxPxR77 to elicit conduit formation and B cell invasion. By interacting with Vav and possibly other kinases, such as p21-activated kinases 11, 12 , 72PxxPxR77 could also inhibit CD40-mediated class switch-inducing signals in B cells. Consistent with that possibility, p21-activated kinase 2 has been found to interfere with CD40 signaling in Nef-containing dendritic cells 52 . Nanotubular conduits establish cytoplasmic continuity with targeted cells, allowing intercellular trafficking of cytoplasmic proteins and organelles 2, 3 . Given its ability to interact with various cytoplasmic proteins such as actin and kinases 11 , Nef could invade B cells not only from the plasma membrane but also from the cytoplasm. Nef could also invade B cells through endosomes, because conduit-associated Nef often localized together with vesicules containing b-adaptin, a component of the clathrin-AP-2 complex 39 . The involvement of clathrin-dependent endocytosis was further indicated by the finding that the transfer of Nef to B cells was attenuated by inactivation of b-arrestin 2 and dynamin Ia, which facilitate the formation of clathrincoated endosomes 41 , or by disruption of 156ExxxLL161, which mediates the interaction of Nef with AP-2 (ref. 38) .
Nef could also traffic to B cells by a clathrin-independent, TGNtargeting endocytic pathway, as some Nef localized together with tubular structures and TGN46 in conduits. In addition, disruption of the Nef motif 62EEEE65, which triggers PACS-1-dependent recruitment of Nef-containing endosomes to the TGN 14 , impaired the trafficking of Nef to B cells. Consistent with its inability to interact with Nef 14 , ARF6, which routs HLA-I-containing endosomes to the TGN 14 , served a marginal function in the trafficking of Nef to B cells. The mechanism by which organelle-associated Nef affects B cell signaling remains unknown. One possibility is that Nef inhibits NF-kB-dependent CSR-inducing signals by interacting with vacuolar ATPase 11, 53 . In addition to using endosomes, Nef may use exosomes or exosome-like structures to target B cells. That possibility is consistent with published data showing dendritic cell internalization of HIV-1 particles to multivesicular endocytic bodies, followed by extracellular release of infectious exocytic vesicles 54 . Nef could enhance this process by promoting the proliferation of multivesicular bodies and remodeling of the actin cytoskeleton 55 .
Nef may also use contact-independent mechanisms to invade immune cells and their precursors. Indeed, B cells and hematopoietic cells become dysfunctional after capturing soluble Nef from the extracellular environment 8, 48 . In vivo, extracellular Nef presumably originates from its passive release by dying infected cells 8, 48, 56 . The absence of substantial cell death in cultures with infected macrophages possibly reflects the lack of the many immune and nonimmune deathinducing signals usually present in vivo and explains why supernatants from these cultures neither contained Nef nor had overt class switchinhibiting activity. Given those considerations, we propose that Nef uses both contact-dependent and contact-independent mechanisms to generate suppressive signals in uninfected bystander B cells. In summary, our work has indicated that HIV-1 exploits Nef-trafficking intercellular connectivity networks to evade virus-specific production of IgG2 and IgA by systemic and intestinal B cells. Thus, small molecules able to inhibit conduit formation and/or Nef function could be useful for enhancing protection against HIV-1.
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ONLINE METHODS
Tissue, blood and serum. Lymph node, spleen, gut and tonsil tissues from 20 HIV-1 + patients with chronic infection and 13 HIV-1 À patients with reactive inflammation were obtained from a repository at the Department of Pathology of Weill Medical College of Cornell University (Supplementary Table 1) . LTNPs with transfusion-acquired infection by DNef HIV-1 or sexually acquired infection by wild-type HIV-1 and control donors matched for age, sex and/or transfusion are from Australia and have been described 45 . The Institutional Review Board of Weill Medical College of Cornell University approved studies involving both tissue and blood specimens, which were obtained from healthy donors and infected patients who provided informed consent.
Cells. IgD + B cells were sorted from the peripheral blood of healthy donors as described 34 . THP-1 cells and U937 cells (American Type Culture Collection) are human myeloid cell lines with macrophage-like properties. U1 is a chronically infected subclone of U937 cells (from AIDS Research and Reference Reagent Program at National Institutes of Health (NIH)). U1 cells expressed HIV-1 after exposure for 24 h to 30 ng/ml of TNF (R&D Systems). Activated U1 cells were washed twice with phosphate buffer solution before use in coculture. Finally, 293T epithelial cells were used in experiments involving wild-type HIV-1 and DNef-HIV-1 virions. Complete RPMI-1640 medium supplemented with 10% FBS was used for culture.
Cultures and reagents. IgD + B cells were cultured together with THP-1 cells, U1 cells, 293 cells or macrophages at a ratio of 2:1. After 48 h, B cells were sorted with biotinylated mouse monoclonal antibody (mAb) HIB19 to CD19 (BD Biosciences PharMingen) and anti-biotin MicroBeads (Miltenyi), then were washed and were seeded at a density of 1 Â 10 5 cells per 100 ml with or without T cell-dependent stimuli, including 100 ng/ml of CD40L (PreproTech) and 30 ng/ml of IL-10 (Sigma-Aldrich). In some experiments, cells were cocultured in the presence of 2 mM azide (Sigma-Aldrich), 2.5 mM latrunculin B, 1 mM colchicine, 10 mM nocodazole, 2.5 mM wortmannin (Calbiochem), 50 nM AD101 (Schering Plough Research Institute) or 50 nM AMD3100 (AnorMed). To obtain macrophages, monocytes sorted with CD14 Microbeads (Miltenyi) were incubated as adherent monolayers in 15-cm tissue culture dishes with complete medium containing 25 ng/ml of monocyte colonystimulating factor (PeproTech) for the initial 2 d and complete medium lacking monocyte colony-stimulating factor for the next 4 d. Differentiated macrophages were treated with trypsin and were seeded into 24-well plates or 3-cm glass-bottomed dishes at a density of 1 Â 10 6 cells per well 1 d before virus infection.
In vitro infection. For the generation of viral stocks, HeLa cells were transfected with 30 mg of plasmid encoding ADA, DNef ADA (from M. Stevenson), LAI or DNef LAI (from B. Berkhout) by calcium phosphate-DNA coprecipitation, followed by incubation at 37 1C. The half-maximal tissue culture infectious dose was measured after collection of virions from culture supernatants by ultracentrifugation. A concentration of 2 Â 10 4 half-maximal tissue culture infectious dose of virus per ml was used in each well or dish. Free virions were washed away 24 h later and newly produced HIV-1 virions from infected macrophages were quantified by ELISA of p24 at d 7 after infection.
Flow cytometry. Spleens were collected from infected patients undergoing post-traumatic splenectomy; the Institutional Review Board of Weill Medical College of Cornell University approved studies involving splenic specimens, and patients provided informed consent. Splenic B cells and macrophages from those spleens and B cells from cocultures with in vitro-infected macrophages were stained with fluorescein-conjugated mAb SJ25-C1 to CD19 or biotinconjugated mAb 61D3 to CD14 (SouthernBiotech), followed by staining with strepatavidin-peridinin chlorophyll protein-cyanine 5.5. Cells were then fixed and made permeable with the Cytofix/Cytoperm Fixation/Permeabilization Solution kit (BD Biosciences PharMingen) and were further stained with goat polyclonal antibody VA-19 to Nef and mAb 24-4 to p24 (Santa Cruz). Alexa Fluor 546-conjugated donkey antibody to goat (anti-goat) and Alexa Fluor 647-conjugated goat anti-mouse IgG2b were used sequentially as secondary reagents. At least 5 Â 10 4 cells were acquired with an LSR II analyzer (BD Biosciences PharMingen).
Immunohistochemistry and immunofluorescence analysis. Paraformaldehydefixed frozen tissue sections 5-15 mm in thickness were blocked for 1 h at 25 1C with 1% (vol/vol) BSA-phosphate buffer solution mixed with whole human IgG or human FcgR-blocking reagent (Miltenyi) and then were stained with the appropriate primary monoclonal or polyclonal antibodies (Supplementary Table 3 ) and secondary reagents as described 8 . Nuclei were visualized with DAPI (4¢,6-diamidine-2¢-phenylindole dihydrochloride; Boehringer Mannheim). Images were acquired with an Axiovert 200M microscope (Carl Zeiss). Control staining and quantification of GC-associated proteins are described in the Supplementary Methods. For visualization of CD19, CD14, Nef and p24 in B cells and macrophages, cells were centrifuged, fixed in methanol and labeled with DAPI and appropriate primary and secondary antibodies (Supplementary Table 3 ).
